AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TuHURA Biosciences, Inc./NV Director's Dealing 2021

Mar 31, 2021

34026_dirs_2021-03-31_8ef54d31-ccec-46c4-ad9e-0f97daed6bfc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kintara Therapeutics, Inc. (KTRA)
CIK: 0001498382
Period of Report: 2021-03-31

Reporting Person: Brown Dennis M (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-31	Common Stock	J	17	—	Acquired	6062	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	53750	Indirect

Footnotes

F1: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.

F2: Held by Valent Technologies LLC, of which the reporting person is the sole member and owner and holds sole voting and dispositive power over its shares.